Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Apellis Pharmaceuticals, Inc.
  6. Consensus
    APLS   US03753U1060

APELLIS PHARMACEUTICALS, INC.

(APLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on APELLIS PHARMACEUTICALS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) APELLIS PHARMACEUTICALS, INC.
Analyst Recommendations on APELLIS PHARMACEUTICALS, INC.
05/24Goldman Sachs Adjusts Apellis Pharmaceuticals' Price Target to $84 from $94, Keeps Buy Rat..
MT
05/20Credit Suisse Raises Apellis Pharmaceuticals' Price Target to $49 from $44, Maintains Neut..
MT
05/05Raymond James Adjusts Apellis Pharmaceuticals' Price Target to $102 from $114, Keeps Stron..
MT
05/05Credit Suisse Raises Apellis Pharmaceuticals' PT to $44 from $40, Says On Track to Submit ..
MT
05/05Wedbush Lifts Apellis Pharmaceuticals' Price Target to $40 From $39, Maintains Neutral Rat..
MT
04/28Wedbush Lifts Price Target on Apellis Pharmaceuticals to $39 From $34, Maintains Neutral R..
MT
04/22Oppenheimer Adjusts Apellis Pharmaceuticals Price Target to $68 From $65, Maintains Outper..
MT
More recommendations
Analysis
Pfizer CEO says Omicron-targeted vaccine is most likely outcome
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 41,95 $
Average target price 71,73 $
Spread / Average Target 71,0%
High Price Target 102,00 $
Spread / Highest target 143%
Low Price Target 40,00 $
Spread / Lowest Target -4,65%
Consensus detail
Consensus revision (last 18 months)